| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8587117 | Clinical Nutrition ESPEN | 2018 | 8 Pages |
Abstract
Future cachexia trials would likely benefit from studying a single tumour type with earlier stage disease, with probably different dosage depending on the cancer type and its inflammatory profile.
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Daryna Sergiyivna Lavriv, Pedro Miguel Neves, Paula Ravasco,